Last reviewed · How we verify

NCT05690087

Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position

Completed NA Last updated 3 January 2024
What this trial tests

NA trial testing Lidocaine in Lidocaine in 66 participants. Completed in 1 January 2024.

Timeline
1 February 2023
Primary endpoint
1 January 2024
1 January 2024

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment66
Start date1 February 2023
Primary completion1 January 2024
Estimated completion1 January 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 35 to 65, female only, with Lidocaine or Optic Nerve Sheath Diameter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We hypothesize that intravenous lidocaine infusion may have beneficial effect to patients undergoing laparoscopic surgeries in Trendelenburg position by preventing ICP elevation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lidocaine

Trials testing the same drug.

Other recruiting trials for Lidocaine

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing